• 188 Citations
  • 4 h-Index
20042019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2004 2019

  • 188 Citations
  • 4 h-Index
  • 5 Article
  • 4 Review article
  • 1 Chapter
2019
109 Citations (Scopus)
docetaxel
Methotrexate
Standard of Care
Therapeutics
Platinum
2017
Radiotherapy
Recurrence
Survival
Squamous Cell Carcinoma
Xerostomia
3 Citations (Scopus)

Phase I study of veliparib in combination with gemcitabine

Stoller, R., Schmitz, J. C., Ding, F., Puhalla, S., Belani, C. P., Appleman, L., Lin, Y., Jiang, Y., Almokadem, S., Petro, D., Holleran, J., Kiesel, B. F., Ken Czambel, R., Carneiro, B. A., Kontopodis, E., Hershberger, P. A., Rachid, M., Chen, A., Chu, E. & Beumer, J. H., Sep 1 2017, In : Cancer Chemotherapy and Pharmacology. 80, 3, p. 631-643 13 p.

Research output: Contribution to journalArticle

gemcitabine
Appointments and Schedules
Pharmacokinetics
Pharmacodynamics
Toxicity
2016

A patient with complex multiple genomic alk alterations

Liu, X., Rice, S. J., Jamis-Dow, C. A., Abendroth, C., Ali, S., Almokadem, S. & Belani, C. P., Apr 2016, In : Thorax. 71, 4, p. 383-385 3 p.

Research output: Contribution to journalReview article

Serine Endopeptidases
Histone-Lysine N-Methyltransferase
Pyrazoles
MAP Kinase Kinase 4
Pyridines
1 Citation (Scopus)

A week in the life of lung cancer survivors: Daily reports of stress, worry, mood, and symptoms

Aronson, K. R., Wagstaff, D. A., Farace, E., Muscat, J., Belani, C., Almokadem, S. & Fossum, T., Oct 1 2016, In : Journal of Health Psychology. 21, 10, p. 2269-2282 14 p.

Research output: Contribution to journalArticle

Survivors
Lung Neoplasms
Interviews
Multilevel Analysis
Survival Rate

Progress in immunotherapy of head and neck squamous cell carcinoma

Almokadem, S., Aug 1 2016, In : Current Molecular Pharmacology. 9, 3, p. 226-230 5 p.

Research output: Contribution to journalReview article

Allergy and Immunology
Immunotherapy
Interleukins
Interferons
Squamous Cell Carcinoma
2013
6 Citations (Scopus)

Impact of genetic markers on treatment of non-small cell lung cancer

Lamparella, N., Barochia, A. & Almokadem, S., Feb 15 2013, Impact of Genetic Targets on Cancer Therapy. El-Deiry, W. (ed.). p. 145-164 20 p. (Advances in Experimental Medicine and Biology; vol. 779).

Research output: Chapter in Book/Report/Conference proceedingChapter

Genetic Markers
Non-Small Cell Lung Carcinoma
Cells
Therapeutics
Clinical Trials
33 Citations (Scopus)

Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancer

Besse, B., Tsao, L. C., Chao, D. T., Fang, Y., Soria, J. C., Almokadem, S. & Belani, C. P., Jan 1 2013, In : Annals of Oncology. 24, 1, p. 92-96 5 p., mds281.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Integrins
Non-Small Cell Lung Carcinoma
Pharmacokinetics
2012
30 Citations (Scopus)

Volociximab in cancer

Almokadem, S. & Belani, C. P., Feb 1 2012, In : Expert Opinion on Biological Therapy. 12, 2, p. 251-257 7 p.

Research output: Contribution to journalReview article

Integrins
Neoplasms
Chemotherapy
Combination Drug Therapy
Fibronectins
2004

Peer viewpoint

Harvey, H. A. & Almokadem, S. M., Nov 1 2004, In : Journal of Supportive Oncology. 2, 6, p. 516-517 2 p.

Research output: Contribution to journalReview article

Parathyroid Hormone-Related Protein
Phase III Clinical Trials
Gallium
Hypercalcemia
Antineoplastic Agents